F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021
August 02 2021 - 9:10AM
F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage
biopharmaceutical company dedicated to developing next generation
immunotherapies to transform the lives of patients with cancer,
announced today that it will release earnings for the quarter
ending June 30, 2021 before market open on August 12, 2021. The
Company will host an investor conference call and webcast that same
day at 9:00 a.m. EST to discuss financial results and provide a
corporate update.
To access the call, participants may join via a
live webcast on the Investors and News section of the F-star
Therapeutics website, under Events and Presentations. To join by
phone, participants may dial 1-833-471-0868 in the US/Canada or
1-914-987-7751 for international calls or 0800 0288438 or 0203
1070289 for the United Kingdom, at least 10 minutes prior to the
start of the call.
A replay of the conference call will be available
for 90 days from the call and may be accessed in the Investors
& News/Events and Presentations section on the F-star
Therapeutics website.
About F-star Therapeutics,
Inc.
F-star is a clinical-stage biopharmaceutical
company developing tetravalent bispecific antibodies for a
paradigm-shift in cancer therapy. By developing medicines that seek
to block tumor immune evasion, the Company’s goal is to offer
patients greater and more durable benefits than current
immuno-oncology treatments. Through its proprietary tetravalent,
bispecific natural antibody (mAb²™) format, F-star’s mission is to
generate highly differentiated best-in-class drug candidates with
monoclonal antibody-like manufacturability. For more information
visit https://www.f-star.com/ and follow us
on LinkedIn and Twitter.
For further information, please
contact:
For investor
inquiriesLindsey TrickettVP Investor
Relations & Communications+1 240 543
7970lindsey.trickett@f-star.com
For media inquiriesHelen
ShikShik Communications
LLC617-510-4373Shik.Helen10@gmail.com
F star Therapeutics (NASDAQ:FSTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
F star Therapeutics (NASDAQ:FSTX)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about F star Therapeutics Inc (NASDAQ): 0 recent articles
More News Articles